Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.
about
The lymph node in HIV pathogenesisModulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory MoleculesCutaneous Leishmaniasis Vaccination: A Matter of QualityPost-Genomics and Vaccine Improvement for LeishmaniaImmunoregulation in human American leishmaniasis: balancing pathology and protectionIL-22 Protects against Tissue Damage during Cutaneous LeishmaniasisCharacterization of anamnestic T-cell responses induced by conventional vaccines against contagious bovine pleuropneumoniaVector transmission of leishmania abrogates vaccine-induced protective immunityChronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infectionIL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infectionRegulation of immunity during visceral Leishmania infectionEffector memory Th1 CD4 T cells are maintained in a mouse model of chronic malariaIn vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopesLive vaccination tactics: possible approaches for controlling visceral leishmaniasisTh1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasisImmunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral LeishmaniasisBlimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis.Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infectionInfection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes.Selected microRNAs define cell fate determination of murine central memory CD8 T cells.Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice modelsAltered T cell memory and effector cell development in chronic lymphatic filarial infection that is independent of persistent parasite antigen.Leishmaniasis Vaccine: Where are We Today?Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infectionLive nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.Anamnestic responses of mice following Mycobacterium tuberculosis infection.Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) populationThe early generation of a heterogeneous CD4+ T cell response to Leishmania major.MHC class II restricted innate-like double negative T cells contribute to optimal primary and secondary immunity to Leishmania majorImmunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice.Oral vaccination with lipid-formulated BCG induces a long-lived, multifunctional CD4(+) T cell memory immune responseAntigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype.Vaccines to prevent leishmaniasis.CD8+ T cells are preferentially activated during primary low dose leishmania major infection but are completely dispensable during secondary anti-Leishmania immunityEarly establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cellsDrug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.Transgenesis and neuronal ablation in parasitic nematodes: revolutionary new tools to dissect host-parasite interactions.Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruziImmunologic response and memory T cells in subjects cured of tegumentary leishmaniasis.
P2860
Q24644783-63C8C862-9D19-4544-B381-B7D4D7378AD9Q26744635-E34430BC-7E5C-4D40-B8FD-7F21712925E9Q26752521-DFEDEACC-BF82-4F01-BB85-BBE29109F2E3Q26752532-46FE5EC1-5F9E-4B9A-9211-3F686A031ACAQ26850280-279FD2A3-9CC5-4DB4-9015-861CBCEE6536Q27301071-ECD746CB-4447-4D84-961D-36B83DEDA78EQ27312726-A29E77D5-3EA5-497D-8953-3AB19C607CF1Q27316727-7B3FAAC9-C2D8-425C-9631-C23E222D201FQ27322520-D2996151-26ED-478C-850F-3EBBD5F18049Q27335548-DF730707-0E5F-4CFA-B908-40E5797D9408Q28066034-416250CC-9270-4F65-9078-B69F611BCD3BQ28476346-A911433E-A9AF-4FB0-AD04-676FEF18921BQ28541967-4AC73129-9ED2-4E8C-BB49-55CA4A3B22EFQ28542081-9D058263-D9F7-44FA-B321-07F746B4DBB2Q28542988-73D6B1FE-5680-446B-BA1A-34711D58CEF8Q28552919-3C42FBFB-CE77-4D21-8B0B-49F72BF2A8F4Q30276224-1186782E-F5F5-41BA-B99B-C4889509114EQ30436432-837B8B1B-D0F6-4749-A2F4-9BD79CAF7752Q33566856-C2240847-B263-45BB-B167-CBA20F7999C5Q33614998-488FA8E0-59BD-48C0-A6EF-83E653B0181DQ33617726-C7FDEEE0-6215-47D0-A8A9-867018E77D49Q33783745-658B12C0-CDA7-4464-BC0C-A750845E1090Q33895052-C7DE1C4C-B871-4809-888A-A878D73E1CB4Q33929859-FDE31A4F-654F-4A09-8347-672939A20A4CQ33946585-85F87D08-71F9-49C8-8474-1146E46A92FCQ34033343-48C4E8EA-10C1-43E3-92A7-9A1F7C9CD2A3Q34034280-9644AD2B-E5C8-48BC-91D3-4898D4861F82Q34111831-5281289E-A592-4280-837C-3BFDA716C84AQ34152201-D772A502-508F-42E6-BE2D-BDC4DD432E62Q34215441-A28F8C3C-85EE-42E4-8156-FFC31EF6D0CFQ34300949-E2659585-2A3E-488E-92C3-D0FAEC96AE2EQ34438532-9C19D6BC-6C44-49B9-B8A8-C7FC45610DFDQ34491852-6B102B23-3A4C-45AB-957D-31C88F90BB66Q34511559-667ADDF4-3056-455F-995A-70E231B18888Q34549643-F85327E6-DB67-4112-B0EF-6259D6A71593Q34694947-7233E7E8-8516-4056-BDB1-7C9B3BA4E5BCQ34783795-9EE2246C-4944-4A8C-8266-F03EE4F8ADD4Q34905028-22B6D3EC-ABA2-45AB-9F29-0FB8E5043C14Q34931648-43935D95-EC5E-44A9-9761-E6F34E577431Q35037274-26DF855B-F84C-4A2D-8452-2539BA12C2F7
P2860
Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Central memory T cells mediate ...... sence of persistent parasites.
@en
Central memory T cells mediate ...... sence of persistent parasites.
@nl
type
label
Central memory T cells mediate ...... sence of persistent parasites.
@en
Central memory T cells mediate ...... sence of persistent parasites.
@nl
prefLabel
Central memory T cells mediate ...... sence of persistent parasites.
@en
Central memory T cells mediate ...... sence of persistent parasites.
@nl
P2860
P356
P1433
P1476
Central memory T cells mediate ...... sence of persistent parasites.
@en
P2093
Jude Uzonna
Phillip Scott
P2860
P2888
P304
P356
10.1038/NM1108
P407
P577
2004-09-26T00:00:00Z